MindfulGarden is the first clinically validated affective biofeedback platform for managing the agitated behaviours associated with delirium while reducing the use of antipsychotics and restraints. Approved by Health Canada as a Class I device in 2024, MindfulGarden is currently in clinical evaluations leading to commercialization in North America and Asia. Patent pending. Foundational study in NATURE's npj/Digital Medicine highlights 25.7% reduction in use of PRN drugs and rapid de-escalation of agitation as measured by RASS.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 583 Beach Crescent, Suite 1106,canada
- cw****@****den.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- mindfulgarden.com
- Keywords
- biofeedback, gerontechnology, BPSD, dementia, delirium, When anxiety is lowered, care begins™, HealthTech, ICU delirium, affective biofeedback.
- HQ
- Vancouver, British Columbia
Mindfulgarden Digital Health Questions
Mindfulgarden Digital Health's website is mindfulgarden.com
Mindfulgarden Digital Health's LinkedIn profile is https://ca.linkedin.com/company/mindfulgarden
Mindfulgarden Digital Health has
3 employees.
View email and phone details for 3
employees at Mindfulgarden Digital Health.
Mindfulgarden Digital Health's industry is
Hospitals and Health Care
Mindfulgarden Digital Health's top competitors are
Medreddie,
Vessl Prosthetics Inc.,
Theravac Biologics,
Synakis,
Neurenati Therapeutics,
Arrayus Technologies Inc.,
Moonrise Medical,
Taumedis,
Stoked Bio,
Yellowbird Diagnostics, Inc..
Mindfulgarden Digital Health's support email address is cwinckler@mindfulgarden.com
Mindfulgarden Digital Health's categories are Hospitals and Health Care
Mindfulgarden Digital Health's founding year is 2020
